| Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer. | endometrial, |
| Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. | lung, |
| A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. | leukemia, |
| Results indicate that miR-134 played a pivotal role on NSCLC through inhibiting cell proliferation, migration, invasion, and promoting apoptosis by targeting oncogenic CCND1. | lung, |
| Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. | lymphoma, |
| Studies uncover a fine-tuned modulation of the proto-oncogene CCND1 in Ewing sarcoma cells via alternative complexes formed by DHX9 with either EWS-FLI1 or pncCCND1_B-Sam68. | sarcoma, |
| Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32). | leukemia, |
| Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. | breast, |
| Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. | cervical, |
| PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. | HNSC, |
| BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. | neoplasm, |
| The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. | colorectal, |
| Human cyclin D1 oncogene and esophageal squamous cell carcinoma. | esophageal, |
| The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. | gastric,tongue, |
| A small deletion in the 3 -untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. | leukemia, |
| Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. | breast, |
| Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. | breast, |
| Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. | skin, |
| Suppression of oncogenic transformation by hypothemycin associated with accelerated cyclin D1 degradation through ubiquitin-proteasome pathway. | None |
| Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. | None |